Industry News

A new report from The Pharmaceutical Care Management Association alleges that FDA hinders competition in the pharmaceutical industry and influences how a drug's price is calculated.

USP releases compendium of quality standards for compounded medicines.

FDA releases guidance specifying its preferred unique facility identifier system.

M&A transactions accounted for nearly $15 billion more this year than for the same period a year ago.

Industry veteran Peter Bigelow to guide PBOA Board.

FDA approved a Cook Pharmica facility and a Patheon facility for manufacturing of Halozyme products.

Boehringer Ingelheim's OFEV was approved by FDA as the first treatment for idiopathic pulmonary fibrosis, a fatal lung disease.

The International Society for Pharmaceutical Engineering (ISPE) released its Drug Shortages Prevention Plan as part of an initiative to address drug shortage prevention due to manufacturing and quality issues.

The Pharmaceutical Research and Manufacturers of America released their 2014 Cancer Report that highlights the biopharmaceutical companies developing new medicines and vaccines used for the treatment of cancer.

CPhI released Part 3 of its annual industry report featuring three experts in the pharmaceutical industry.

New investments, expansions, and company rebranding are discussed at CPhI.

CPhI released Part 2 of its annual industry report focused on the future of the pharmaceutical industry.

Celebrating the best of pharma and recognizing companies that turn inspiration into innovation.

CPhI released Part 1 of its annual industry report focused on innovation in the market.

USP expresses its support for a consensus-based global approach to the naming of biologics.

Meeting increasing expectations and escalating regulatory requirements to protect patients.

Alchem International announced that it will continue to market and support Tropane Alkaloid APIs despite earlier reports.

The University of Limerick will be the headquarters for a new $6.4-million research and innovation center.

FDA releases guidance on ANDAs and PASs submissions to help applicants avoid deficiencies.

Molecular Profiles has expanded its capsule filling capability following significant investment into new equipment at its clinical manufacturing site in the United Kingdom.

European Commission granted the first biosimilar insulin to receive regulatory approval in Europe.

PDA will publish a technical report on quality risk management aspects of drug shortages in early 2015.

ProBioGen, a biopharmaceutical drug manufacturer in Berlin, spends ?20 million to double its workforce.

Three-year agreement will support research on treatments for major brain disorders in Neuroscience Catalyst project.

Natoli Engineering Company partnered with the Brooklyn campus of Long Island University to open the Natoli Institute for Industrial Pharmacy Research and Development.Natoli Engineering Company announced the opening of the Natoli Institute for Industrial Pharmacy Research and Development. The institute was opened in partnership with the Arnold and Marie Schwartz College of Pharmacy and Health Sciences on the Brooklyn campus of Long Island University and features suites for dispensing, formulation, compression, and coating.

Travtec, a packaging line solutions specialist, has opened a second facility close to its Leigh, Lancashire headquarters. This move is part of an investment to expand the company?s operations to meet continuing demand for its systems, particularly as the pharmaceutical industry prepares for the current and forthcoming track and trace legislation, including the 2017 European Falsified Medicines Directive.

DPT Laboratories acquired Media Pharmaceuticals' Lakewood, New Jersey facilities, providing space for aseptic processing suites and filling equipment.

Catalent's addition of an automated prefilled syringe clinical packaging line at its Philadelphia facility will support its work with Eli Lilly.

Meggle Group Wasserburg has been granted an EXCiPACT certificate.

Conventional tablets may no longer be the go-to solution.